TUESDAY, July 11, 2023 (HealthDay News) — Scientists have developed an artificial intelligence (AI) tool capable of deciphering a brain tumor’s genetic code in real time, during surgery — an advance they say could speed diagnosis and personalize patients’ treatment. The researchers trained the AI tool to recognize the differentContinue Reading

TUESDAY, July 11, 2023 (HealthDay News) — Identifying genetic disorders in newborns and infants can help them get the care they need, but one approach — whole genome sequencing — appears far superior to another. In a new study, researchers compared whole genome sequencing with targeted gene-sequencing. They found thatContinue Reading

TUESDAY, July 11, 2023 (HealthDay News) — Using marijuana regularly might increase the risk for complications during and after surgery, and doctors should address this when planning operations, a new study suggests. People with a cannabis use disorder are 20% more likely to have serious complications, such as stroke orContinue Reading

THURSDAY, July 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Thursday gave full approval to the Alzheimer’s drug Leqembi, clearing the way for insurance coverage of the pricey drug. “The full FDA approval will open the floodgates for people with early Alzheimer’s to get this drug.Continue Reading

THURSDAY, July 6, 2023 (HealthDay News) — When frail patients go into cardiac arrest and need cardiopulmonary resuscitation (CPR) during surgery, they’re more likely to die than those who are stronger, a new study shows. Researchers from Brigham and Women’s Hospital in Boston studied the impact of frailty on survivalContinue Reading

MONDAY, July 3, 2023 (HealthDay News) — The trendy weight-loss drug Ozempic could be dangerous for a patient undergoing anesthesia for an operation, according to a new warning from the American Society of Anesthesiologists. Semaglutide (Ozempic, Wegovy) and other drugs of their class known as GLP-1 receptor agonists cause digestionContinue Reading

TUESDAY, June 27, 2023 (HealthDay News) — An experimental drug appears to outperform the trendy medications Wegovy and Ozempic for both weight loss and diabetes control, a pair of early clinical trials shows. Retatrutide helped people with obesity drop about one-quarter of their starting weight, on average, during 48 weeksContinue Reading